Search

Displaying results 1391 - 1400 of 10000 in total
  1. Drug

    Vurolenatide

    go.drugbank.com/drugs/DB18440
    Investigational

    Vurolenatide is a recombinant fusion protein comprising exenatide and XTEN.

    Synonyms: L-HISTIDYLGLYCYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-LEUCYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA., -GLUTAMYL-L-.ALPHA.-GLUTAMYL-L-ALANYL-L-VALYL-L-ARGINYL-L-LEUCYL-L-PHE
  2. Drug

    Col-Treg

    go.drugbank.com/drugs/DB18451
    Experimental

    Col-Treg is an autologous T-cell therapy comprising type I regulatory T-cells specific for human type II collagen.[A261635]

    Synonyms: Purified autologous type 1 regulatory T lymphocytes specific for human type II collagen
  3. Drug

    AVID-200

    go.drugbank.com/drugs/DB18454
    Investigational

    AVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.

    Synonyms: Tgf-beta 1/3 inhibitor avid200, Tgf-.beta. ligand trap comprised of tgf-.beta. receptor ectodomains fused to a human fc domain (avid-200)
  4. Drug

    UV1

    go.drugbank.com/drugs/DB18470
    Experimental

    UV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit

  5. Drug

    Emerfetamab

    go.drugbank.com/drugs/DB18474
    Investigational

    Emerfetamab is a bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor.

  6. Drug

    ISB 1442

    go.drugbank.com/drugs/DB18475
    Investigational

    ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47

  7. Drug

    BCX10013

    go.drugbank.com/drugs/DB18496
    Investigational

    BCX10013 is a small molecule inhibitor of human complement factor D.

  8. Drug

    BBP-671

    go.drugbank.com/drugs/DB18498
    Investigational

    BBP-671 is a small molecule activator of pantothenate kinases.

  9. Drug

    MDR-101

    go.drugbank.com/drugs/DB18513
    Investigational

    MDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells

  10. Drug

    DSP-5336

    go.drugbank.com/drugs/DB18514
    Investigational

    DSP-5336 is a menin inhibitor.

    Synonyms: BENZAMIDE, 5-FLUORO-2-((4-(7-(((1S,3S,4R)-5-METHYLENE-2-AZABICYCLO(2.2.2)OCT-3-YL)CARBONYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-N,N-BIS(1-METHYLETHYL)-